CLINICAL_TRIALS
trial_result
· 2023-10-26
Clinical Trial Update: A Study of Rotigotine Patch in Adolescent Subjects With Restless Legs Syndrome of Unknown Cause [Phase 3]
Summary
Phase 3 clinical trial of a rotigotine patch in adolescents with Restless Legs Syndrome was terminated; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: UCB Biopharma SRL | Conditions: Restless Legs Syndrome | Phase 3 | Status: TERMINATED | Results posted: 2023-10-26